Lin, Donna Shu-Han

The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials

Lin, D. S.-H., Lee, J.-K., Hung, C.-S., & Chen, W.-J. (2021) · Diabetologia

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 108

Clinical adverse events associated with sodium-glucose cotransporter 2 inhibitors: a meta-analysis involving 10 randomized clinical trials and 71 553 individuals

Lin, D. S.-H., Lee, J.-K., & Chen, W.-J. (2021) · The Journal of Clinical Endocrinology & Metabolism

Diabetes Treatment and ManagementPharmacovigilance and Adverse Drug Reactions

Cited by 97

Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors

Lin, D. S.-H., Lee, J.-K., & Chen, W.-J. (2021) · Diabetologia

Diabetes Treatment and ManagementPeripheral Artery Disease Management

Cited by 68

Incidence and progression of diabetic retinopathy in patients treated with glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a population-based cohort study

Lin, D. S., Lo, H., Huang, K., Lin, T., Lee, J., & Lin, L. (2024) · Diabetes, Obesity and Metabolism

Retinal Diseases and TreatmentsDiabetes Treatment and Management

Cited by 16